The reason that dialyzers hold one of the most leading manufacturers in the world market is, more than anything else, due to their superior efficacy in substance removal and their biocompatibility, as well as their gentleness on the patient. This naturally includes the removal of -microglobulins, the cause of carpal tunnel syndrome often found in long-term dialysis patients, as well as the separation of uremic toxins from the high molecular weight albumin proteins and the lowering of side-effects such as itching and pain.
The change in the marker elements that are a measure of biocompatibility is extremely low as well, and, in addition, our products possess other special characteristics that are world-renowned. Furthermore, a major feature in dialyzers is based on our proprietary patented technology which insures that no blood remains in the dialyzer after dialysis.
Hemoflow Low-Flux
Capillary Dialysers
Clearances (ml/min)
QB = 200/300ml/min,
QD = 500ml/min,
UF = 0 |
Urea
Creatinine
Phosphate
Vitamin B12 |
|
125
95
50
20 |
155/183
128/145
78/88
32/34 |
170/206
149/175
103/115
45/47 |
180/222
164/175
123/145
45/47 |
184/236
169/210
132/145
60/62 |
186/240
172/216
138/165
76/82 |
| |
1.7 |
2.8 |
4.0 |
5.5 |
6.4 |
7.5 |
| V (blood priming Volume) |
ml |
|
28 |
42 |
63 |
82 |
98 |
110 |
| P (pressure drop blood, QB=300ml/min) |
mmHg |
| P (pressure drop dialysate, QD=500ml/min) |
mmHg |
|
195
14 |
120
13 |
82
12 |
60
11 |
52
10 |
45
9 |
| A (effective surface area) |
m2 |
|
0.4 |
0.7 |
1.0 |
1.3 |
1.6 |
1.8 |
Sterilisation method |
ETO |
